Home Cart 0 Sign in  
X

[ CAS No. 56-91-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 56-91-7
Chemical Structure| 56-91-7
Chemical Structure| 56-91-7
Structure of 56-91-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 56-91-7 ]

Related Doc. of [ 56-91-7 ]

Alternatived Products of [ 56-91-7 ]

Product Details of [ 56-91-7 ]

CAS No. :56-91-7 MDL No. :MFCD00010203
Formula : C8H9NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :QCTBMLYLENLHLA-UHFFFAOYSA-N
M.W : 151.16 Pubchem ID :65526
Synonyms :
Aminomethylbenzoic acid;α-Amino-p-toluic acid

Calculated chemistry of [ 56-91-7 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 41.07
TPSA : 63.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.32 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.07
Log Po/w (XLOGP3) : -1.55
Log Po/w (WLOGP) : 0.69
Log Po/w (MLOGP) : 1.05
Log Po/w (SILICOS-IT) : 0.82
Consensus Log Po/w : 0.42

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.07
Solubility : 128.0 mg/ml ; 0.847 mol/l
Class : Very soluble
Log S (Ali) : 0.73
Solubility : 807.0 mg/ml ; 5.34 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -1.8
Solubility : 2.4 mg/ml ; 0.0159 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 56-91-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 56-91-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 56-91-7 ]
  • Downstream synthetic route of [ 56-91-7 ]

[ 56-91-7 ] Synthesis Path-Upstream   1~59

  • 1
  • [ 619-65-8 ]
  • [ 56-91-7 ]
YieldReaction ConditionsOperation in experiment
84% With hydrogen In methanol for 16 h; A mixture of 4-cyano benzoic acid (500 g, 3.4 mol) and Raney Nickel (100 g) in methanol (5 L) was hydrogenated at a pressure of 10 kg for 16 h. The catalyst was removed by filtration, followed by the removal of the solvent under reduced pressure to afford 4-(aminomethyl)benzoic acid (430 g, 84percent) as a white solid.
Reference: [1] Patent: US2008/51397, 2008, A1, . Location in patent: Page/Page column 23
[2] Journal of the Chemical Society, 1944, p. 678
[3] Patent: US4634689, 1987, A,
  • 2
  • [ 53148-13-3 ]
  • [ 56-91-7 ]
YieldReaction ConditionsOperation in experiment
95.8%
Stage #1: at 20℃; for 3.5 h;
Stage #2: With hydrogenchloride In water
62 g of methyl 4-hydroxyiminomethylbenzoate obtained as above, 600 g of water, 55.4 g (4.0 eq) of sodium hydroxide and 4.5 g of 5 wt percent Pd/C (wet 50percent water) were placed in a 1 L autoclave, and the reaction was carried out under conditions of a hydrogen pressure of 10 kg/cm2, room temperature, a stirring rate of 1500 rpm, and a time of 3.5 hr. After the catalyst was removed, 145.2 g of conc. hydrochloric acid was added so that the solution was neutralized to pH 7, and water was then removed to concentrate the solution.The concentrated solution was then filtered and dried, thus obtaining 4-aminomethylbenzoic acid.; These examples were performed in the same manner as in Example 5, with the exception that the amount of NaOH added was changed to 48.5 g (3.5 eq), 33.7 g (2.4 eq), and 41.6 g (3.0 eq). The different results relative to the amount of added NaOH are given in Table 2 below.
Reference: [1] Patent: US2012/296114, 2012, A1, . Location in patent: Page/Page column 4
[2] Patent: EP2524909, 2012, A2, . Location in patent: Page/Page column 6
  • 3
  • [ 18469-52-8 ]
  • [ 56-91-7 ]
YieldReaction ConditionsOperation in experiment
87% at 50℃; for 1.5 h; 2) adding methyl 4-aminomethylbenzoate to the concentrated sulfuric acid solution,The molar ratio of sulfuric acid to 4-aminomethylalkyl benzoate is 1:1.The reaction was stirred at 50 ° C for 1.5 h, and after the reaction was completed, it was cooled to room temperature.Add water (the amount of water is 20 times the amount of methyl 4-aminomethylbenzoate), then add sodium hydroxide solution dropwise to the solution to make the solution alkaline.There is a lot of solids to precipitate, filter, wash,And dried to give a white solid aminomethylbenzoic acid.
Reference: [1] Patent: CN108623488, 2018, A, . Location in patent: Paragraph 0037; 0039; 0053
[2] Patent: EP1724263, 2006, A1, . Location in patent: Page/Page column 24
  • 4
  • [ 366-84-7 ]
  • [ 56-91-7 ]
YieldReaction ConditionsOperation in experiment
91% at 80℃; for 1 h; 2) adding ethyl 4-aminomethylbenzoate to the concentrated sulfuric acid solution,The molar ratio of sulfuric acid to 4-aminomethylalkyl benzoate is 2:1,The reaction was stirred at 80 ° C for 1 h, and after completion of the reaction, it was cooled to room temperature.Add water (the amount of water is 20 times the amount of methyl 4-aminomethylbenzoate), then add ammonia water dropwise to the solution to make the solution alkaline.There is a lot of solids to precipitate, filter, wash,Drying gave a white solid aminotoluic acid.
Reference: [1] Patent: CN108623488, 2018, A, . Location in patent: Paragraph 0040; 0042; 0043; 0045; 0046; 0048; 0053
  • 5
  • [ 53148-13-3 ]
  • [ 56-91-7 ]
  • [ 3477-93-8 ]
Reference: [1] Patent: EP2524909, 2012, A2, . Location in patent: Page/Page column 5-6
  • 6
  • [ 2627-86-3 ]
  • [ 619-66-9 ]
  • [ 56-91-7 ]
  • [ 98-86-2 ]
Reference: [1] Journal of Molecular Catalysis B: Enzymatic, 2014, vol. 100, p. 32 - 39
  • 7
  • [ 619-66-9 ]
  • [ 56-91-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 21, p. 6197 - 6208
  • 8
  • [ 10406-25-4 ]
  • [ 56-91-7 ]
Reference: [1] Patent: US5777158, 1998, A,
  • 9
  • [ 1571-08-0 ]
  • [ 56-91-7 ]
Reference: [1] Patent: US2012/296114, 2012, A1,
[2] Patent: EP2524909, 2012, A2,
  • 10
  • [ 303795-50-8 ]
  • [ 56-91-7 ]
Reference: [1] Chemische Berichte, 1890, vol. 23, p. 1061
  • 11
  • [ 34040-64-7 ]
  • [ 56-91-7 ]
Reference: [1] Patent: CN108623488, 2018, A,
  • 12
  • [ 1201-90-7 ]
  • [ 56-91-7 ]
Reference: [1] Patent: CN108623488, 2018, A,
  • 13
  • [ 3477-93-8 ]
  • [ 56-91-7 ]
Reference: [1] Journal of Organic Chemistry, 1973, vol. 38, p. 2185
  • 14
  • [ 120-61-6 ]
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
[2] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
  • 15
  • [ 42967-55-5 ]
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
  • 16
  • [ 7377-26-6 ]
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
  • 17
  • [ 1129-35-7 ]
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
  • 18
  • [ 6232-88-8 ]
  • [ 56-91-7 ]
Reference: [1] Journal of the Chemical Society, 1946, p. 466
  • 19
  • [ 150-13-0 ]
  • [ 56-91-7 ]
Reference: [1] Journal of the Chemical Society, 1944, p. 678
  • 20
  • [ 17201-43-3 ]
  • [ 56-91-7 ]
Reference: [1] Journal of the Chemical Society, 1946, p. 466
  • 21
  • [ 6757-31-9 ]
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
  • 22
  • [ 7647-01-0 ]
  • [ 303795-50-8 ]
  • [ 56-91-7 ]
Reference: [1] Chemische Berichte, 1890, vol. 23, p. 1061
  • 23
  • [ 67-56-1 ]
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
YieldReaction ConditionsOperation in experiment
92% for 6 h; Heating / reflux To a solution of 4-(aminomethyl)benzoic acid (300 g, 1.98 mol) in methanol (5 L) was added thionylchloride (473 g 3.97 mol). The reaction mixture was refluxed for 6 h, followed by the removal of the solvent under reduced pressure to obtain the crude product. The crude was purified by acid-base work up to afford methyl-4-(aminomethyl)benzoate (300 g, 92percent) as a liquid.
88%
Stage #1: With hydrogenchloride In water for 7 h; Heating / reflux
Stage #2: With sodium hydroxide In methanol; dichloromethane; water at 5 - 10℃;
EXAMPLE
In a 1200 1 stirred vessel made of steel and enamel, 60 kg of 4-(aminomethyl)benzoic acid, 480 kg of methanol and 89 kg of 30percent hydrochloric acid are heated to boiling at reflux.
After a reaction time of 7 h, the reaction mixture is cooled to 10° C.
Addition of 290 kg of 4percent sodium hydroxide solution initially adjusts the pH of the reaction mixture to a pH of 6-7, before a methanol/water mixture is distilled off under reduced pressure.
Subsequently, 400 kg of methylene chloride are added and the pH of the aqueous phase is adjusted to a value of 10-11 at a temperature of 5-10° C.
The lower organic phase is removed.
The aqueous phase is extracted once more with 265 kg of methylene chloride.
The organic phases are combined and stored at 0-5° C.
The content of the solution is determined by means of quantitative HPLC chromatography.
The yield of methyl 4-(aminomethyl)benzoate is 88-89percent.
82% With thionyl chloride In methanol at 0 - 60℃; for 12 h; Intermediate VI: methyl (2E)-3-14-(AMINOMETHVLOPHENYLLACRVLATE, HYDROCHLORIDE SALT; 5 TEP A) FO/WON of methyl-(4-aminomethyl)benzoate; To a solution of (4-aminomethyl) benzoic acid (125 g, 0.83 mol) in methanol (1.5 L) was added THIONYLCHLORIDC (350 g, 3 eq. ) at 0°C with stirring and then allowed to stir at rt for overnight and finally REFLUXED at 60°C for 12 H for the completion of the reaction. The reaction mixture was concentrated and crude hydrochloric salt was neutralized using 10percent aqueous NaHCO3 solution to pH 8. The aqueous layer was concentrated and kept at 0°C overnight. The solid obtained was filtered, washed with cold water and dried under suction to give the title compound (112 g, 82percent).
79% at 70℃; for 3.5 h; 4-aminomethyl benzoic acid (6.69 g, 44.09 mmol) was dissolved methanol (200 mL). SOCl2 (12 mL) was added via syringe. The mixture was stirred at 70°C for 3.5 h. After cooling, the reaction mixture was evaporated and the crude product was dissolved in CH2Cl2 (500 mL). The organic layer was washed with aqueous K2CO3 10percent (300 mL), dried with MgSO4, filtered and evaporated. Methyl 4-(aminomethyl)benzoate was obtained (5.78 g, 79 percent) as a white solid. [] MW: 165.19; Yield: 79 percent; White Solid; Mp (°C): 73.3.1H-NMR (CDCl3,δ): 1.53 (s, 2H, NH2), 3.94 (s, 1H, CH3), 3.96 (s, 2H, N-CH2), 7.39 (d, 2H, J = 8.4 Hz, ArH), 8.02 (d, 2H, J = 8.4 Hz, ArH).
37% With hydrogenchloride In waterReflux Step 1.
Synthesis of methyl 4-(aminomethyl)benzoate
To a solution of 4-(aminomethyl)benzoic acid (0.500 g, 3.31 mmol) in methanol (15.0 mL) was added concentrated HCl(aq) (0.8 mL).
After the reaction mixture was reflux for overnight and cooled to room temperature, the solvent was removed under reduced pressure.
The residue was partitioned between ethyl acetate and water.
The organic layer was dried over MgSO4(s), filtered, and concentrated to give a residue.
The residue was purified by Isco Combi-Flash Companion column chromatography (100percent ethyl acetate and 15percent MeOH in CH2Cl2) to give methyl 4-(aminomethyl)benzoate (200 mg, 37percent).
1H NMR (CDCl3, 400 MHz) δ 7.98 (d, 2H), 7.36 (d, 2H), 3.91 (s, 2H), 3.88 (s, 3H).

Reference: [1] Patent: US2008/51397, 2008, A1, . Location in patent: Page/Page column 23
[2] Patent: US2007/149802, 2007, A1, . Location in patent: Page/Page column 2-3
[3] Patent: WO2005/12280, 2005, A1, . Location in patent: Page/Page column 51-52
[4] Patent: EP1541549, 2005, A1, . Location in patent: Page/Page column 25; 42
[5] European Journal of Inorganic Chemistry, 2013, # 7, p. 1149 - 1156
[6] Patent: US2017/253569, 2017, A1, . Location in patent: Paragraph 0897-0898
[7] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 5, p. 483 - 486
[8] Journal of Medicinal Chemistry, 2004, vol. 47, # 2, p. 467 - 474
[9] Patent: WO2011/28741, 2011, A1, . Location in patent: Page/Page column 228
[10] Patent: WO2011/37610, 2011, A1, . Location in patent: Page/Page column 54
[11] Journal of the American Society for Mass Spectrometry, 2018, vol. 29, # 4, p. 694 - 703
  • 24
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
YieldReaction ConditionsOperation in experiment
94% With chloro-trimethyl-silane In methanol 2-6.
Synthesis of Methyl 4-(Aminomethyl)benzoate Compound of Chemical Formula 13
The mixture of 4-(aminomethyl)benzoic acid (1.0 g, 6.61 mmol) and chlorotrimethylsilane (3.35 mL, 26.44 mmol) was stirred for 30 minutes at room temperature, and anhydrous methanol (20 mL) was added thereto.
The reaction mixture was stirred for 48 hours and then vacuum distilled to give methyl 4-(aminomethyl)benzoate (1.25 g, 94percent).
1H NMR (500 MHz, D2O) δ 8.02 (d, 2H, J=6.4 Hz), 7.51 (d, 2H, J=8.2 Hz), 4.20 (s, 2H), 3.88 (s, 3H).
Reference: [1] Patent: US2014/350227, 2014, A1, . Location in patent: Page/Page column
[2] Angewandte Chemie, International Edition, 2015, vol. 54, # 1, p. 276 - 279[3] Angewandte Chemie, 2015, vol. 127, # 1, p. 278 - 281,4
  • 25
  • [ 120-61-6 ]
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
[2] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
  • 26
  • [ 42967-55-5 ]
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
  • 27
  • [ 7377-26-6 ]
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
  • 28
  • [ 1129-35-7 ]
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
  • 29
  • [ 6757-31-9 ]
  • [ 56-91-7 ]
  • [ 18469-52-8 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 3, p. 444 - 448
  • 30
  • [ 56-91-7 ]
  • [ 39895-56-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2018, vol. 61, # 13, p. 5719 - 5732
[2] Chemistry - A European Journal, 2012, vol. 18, # 5, p. 1383 - 1400
[3] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 10, p. 3165 - 3168
[4] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 1, p. 161 - 175
[5] Patent: EP748310, 1999, B1,
[6] Patent: US5827881, 1998, A,
[7] Angewandte Chemie - International Edition, 2010, vol. 49, # 37, p. 6633 - 6637
[8] Steroids, 2012, vol. 77, # 12, p. 1177 - 1191,15
[9] Steroids, 2012, vol. 77, # 12, p. 1177 - 1191
[10] Journal of Medicinal Chemistry, 2012, vol. 55, # 23, p. 10460 - 10474
[11] Patent: WO2013/109859, 2013, A1, . Location in patent: Paragraph 0298
[12] RSC Advances, 2013, vol. 3, # 38, p. 17150 - 17155
[13] Patent: WO2017/100154, 2017, A1, . Location in patent: Paragraph 00120
  • 31
  • [ 56-91-7 ]
  • [ 64-17-5 ]
  • [ 366-84-7 ]
YieldReaction ConditionsOperation in experiment
90% at 20℃; for 4.5 h; Cooling with ice; Reflux Example 1 Preparation of p-aminomethylbenzoic acid ethyl ester
In 250mL neck round bottom flask was added 7.5g (50mmol) p-aminomethylbenzoic acid. Added with 100mL anhydrous ethanol. In an ice bath, was slowly added thionyl chloride 20.8g (175mmol), after the addition was complete, stirring at room temperature after 30min, was heated at reflux for 4h. After stopping the heating, removal of the ethanol under reduced pressure to give a white solid. The solid was dissolved with 150mL ethyl acetate in an ice bath was slowly added 35percent NaOH aqueous solution to pH 7-8. Still stratification, washed three times with saturated saline aqueous layer was removed, and the organic layer, each 30mL. Dried over anhydrous sodium sulfate, filtered, and concentrated to give a yellow solid, 90percent yield.
Reference: [1] Patent: CN104016942, 2016, B, . Location in patent: Paragraph 0090; 0091; 0092
[2] Journal of the American Chemical Society, 1943, vol. 65, p. 2281,2283
[3] Organic and Biomolecular Chemistry, 2013, vol. 11, # 36, p. 6023 - 6028
[4] Journal of the American Society for Mass Spectrometry, 2018, vol. 29, # 4, p. 694 - 703
  • 32
  • [ 56-91-7 ]
  • [ 366-84-7 ]
Reference: [1] Patent: EP976722, 2000, A1,
  • 33
  • [ 56-91-7 ]
  • [ 366-84-7 ]
Reference: [1] Patent: US5834468, 1998, A,
  • 34
  • [ 56-91-7 ]
  • [ 24424-99-5 ]
  • [ 33233-67-9 ]
YieldReaction ConditionsOperation in experiment
97%
Stage #1: With sodium hydrogencarbonate In tetrahydrofuran; water for 16 h;
Stage #2: With hydrogenchloride; water In tetrahydrofuran
Stage 1 - Boc protection; 4-(Aminomethyl)benzoic acid (10.0Og, 65.36mmol) was stirred with BoC2O (28.0Og, 130.72mmoi) in H2O (10OmL) and THF (10OmL) at RT. Sat NaHCO3(aq) was added until pH ~ 6 was reached and the reaction was allowed to stir for 16h. The reaction was then carefully acidified to pH ~ 3 with 1 M HCIaq which caused a solid to precipitate out. This EPO <DP n="62"/>60 was filtered and dried to give the product as a white solid (16.1g, 97percent). m/z = 274 [M+Na]+.
97%
Stage #1: With sodium hydrogencarbonate In tetrahydrofuran; water at 20℃; for 16 h;
Stage #2: With hydrogenchloride; water In water
Example 73; Cvclopentyl (2S)-cvclohexyl((4-r({3-r(1 E)-3-(hvdroxyamino)-3-oxoprop-1-en-1- yl1benzyl)amino)rnethvπbenzyl)amino)acetate; <n="59"/>The title compound was prepared by the following methodology:Intermediate J1Stage 4NaBH(OAc)3, DCEExample 12 ioxane Stage 1 - Preparation of 4-[(te/t-butoxycarbonyl)amino]methyl}benzoic acid; 4-(Aminomethyl)benzoic acid (10.0Og1 65.36mmol) was stirred with BoC2O (28.0Og, 130.72mmol) in H2O (10OmL) and THF (10OmL) at RT. Sat. NaHCO3 solution was added until pH ~ 6 was reached and the reaction was allowed to stir for 16h. The reaction was then carefully acidified to pH ~ 3 with 1 M HCIaq which caused a solid to precipitate out. This was filtered and dried to give the product as a white solid (16.1g, 97percent). m/z = 274 [M+Na]+.
96%
Stage #1: With sodium hydroxide In ethanol; water at 0 - 20℃;
Stage #2: With citric acid In water
4-Aminomethylbenzoic acid (10.0 g, 66 mmol) was dissolved in a mixture of 10 percent aqueous NaOH (90 niL) and EtOH (250 mL). The solution was cooled to 0 0C and di-tert-butyl- dicarbonate (15.2 g, 73.0 mmol) was added slowly. The reaction mixture was stirred for 18 h at ambient temperature and TLC showed the consumption of amino acid. The ethanol was removed in vacuo and water (500 mL) was added. The aqueous layer was acidified slowly with a saturated solution of citric acid (20 mL) and the precipitate formed was filtered under suction, and dried in vacuo to afford the title compound as a white solid. No further purification was required. Yield: 16.0 g, 96 percent. 1H NMR (300 MHz, CDCl3) δ ppm 7.88 (2H, d, J 8.1 Hz), 7.45 (IH, br s), 7.33 (2H, d, J 8.1 Hz), 4.18 (2H, d), 1.30 (9H, s)
92%
Stage #1: With potassium carbonate In water at 20 - 40℃; Cooling with ice
Stage #2: With citric acid In water
(1)
Synthesis of 4-[(tert-butoxycarbonylamino)methyl]benzoic acid
2.00 g (13.2 mmol) of 4-(aminomethyl)benzoic acid suspended in water (20 ml) was mixed with 3.81 g (27.6 mmol) of potassium carbonate and then with 3.57 g (16.4 mmol) of di-tert-butyl bicarbonate under cooling with ice.
The mixture was allowed to react at 40° C. for 2.5 hours and stirred at room temperature overnight.
Then, water (7 ml) and 5.6 g of citric acid monohydrate were gradually added, and the precipitated solid was collected by filtration, washed with water and dried under reduced pressure to obtain the desired product (3.05 g, yield 92percent).
92% With sodium hydroxide In 1,4-dioxane; water at 0℃; for 1 h; 4-(Aminomethyl)benzoic acid (5.0 g, 33.1 mmol) was dissolved in a mixture of dioxane (60mL), H2O (30 mL) and 1 M NaOH (40 mL). The resulting solution was cooled to 0 °C in an ice bath and di-tert-butyl dicarbonate (7.46 g, 34.2 mmol) was added. The reaction mixture was stirred for 1 h at 0 °C and a white precipitate was formed. The solvent was concentrated to 40 mL under reduced pressure and 1 M NaHSO4 solution was added to adjust the pH value to 2. The resulting suspension was extracted with EtOAc (ca. 100 mL) and the organic layer was washed with brine and dried (Na2SO4). The solvent was removed under reduced pressure to yield 9. Colorless solid, mp 169 °C, yield 7.63 g (92 percent). C13H17NO4 (251.1). Rf = 0.18 (ethyl acetate:cyclohexane = 1:1, detection: 254 nm). 1H NMR (400 MHz, DMSO-D6): δ [ppm] = 1.39 (s, 9H, (H3C)3C), 4.19 (d, J = 6.2 Hz, 2H, NHCH2), 7.34 (d, J = 8.0 Hz, 2H, 3-HB, 5-HB), 7.46 (t, J = 6.1 Hz, 1H, NHCH2), 7.89 (d, J = 8.1 Hz, 2H, 2-HB, 6-HB), 12.84 (s, 1H, CO2H). 13C NMR (101 MHz, DMSO-D6): δ [ppm] = 28.2 (3C, (H3C)3C), 43.2 (1C, NHCH2), 77.9 (1C, (H3C)3CO), 126.9 (2C, C-3B, C-5B), 129.2 (1C, C-1B), 129.3 (2C, C-2B, C-6B), 145.3 (1C, C-4B), 155.8 (1C, OCONH), 167.2 (1C, CO2H). FT-IR: ν [cm-1] = 3352 (N-H) 3074 (C-HAr), 2982, 2932, 2886, 2839 (C-Haliph.) 2677, 2558 (CO2H), 1682 (C=O), 1612, 1578, 1504 (C=CAr), 1427 (C-Haliph. deform.), 1242 (C-Ctert-butyl), 1161 (C-O), 841 (Arout of plane). HRMS (APCI): m/z = 252.1233 (calcd. 252.1230 for C13H18NO4 [M+H]+). HPLC: tR = 17.8 min, purity 99.9 percent.
90%
Stage #1: With triethylamine In 1,4-dioxane; water for 16 h;
Stage #2: With phosphoric acid In water at 0℃;
A solution of 4-aminomethylbenzoic acid (5.67 g, 37.5 mmol) triethylamine (5.20 mL, 37.5 mmol) and di-tert-butyl dicarbonate (9.5 mL, 41.2 mmol) in aqueous 1,4-dioxane (1/1) was stirred for 16 hours, reduced in volume under vacuum, cooled to 0 °C, acidified with 1M H3PO4, then extracted with ethyl acetate. The organic phase was washed with water and brine, dried (MgSO4) and evaporated to provide the title compound (8.47 g, 90percent). MS (APCI-) m/e 250 (M- H)-.
86% With sodium hydroxide In tetrahydrofuran; water for 12 h; Preparation of 4-[(tert-Butoxycarbonyl)aminomethyl]benzoic acidTo a solution of commercially available 4-aminomethylbenzoic acid (10.078 g, 66.7 mmol, 1 eq.) in aqueous NaOH (5.866 g, 146.6 mmol, 2.2 eq.) in water (25 ml) and THF (tetrahydrofuran; 50 ml) was added di-te/t-butyl dicarbonate (16 g, 73.3 mmol, 1.1 eq.). After stirring for 12 h the mixture was washed with hexane (2 x 50 ml), the aqueous phase cooled to 5° C and adjusted to pH3 with aqueous saturated citric acid. The resulting white precipitate was extracted with ethyl acetate (3 x 50 ml) and the organic extracts combined and dried (MgSO4). Concentration in vacuo yielded the title carbamate as white needles (14.43 g, 86percent) from EtOAc.R, = 0.43 (SiO2 petrol: EtOAc; 1 :3); υmax (neat)/cm~1 3357 (m), 2968 (w), 2930 (w), 2884 (w), 2488 (m), 1682 (s), 1510 (m), 1409 (m), 1291 (m), 1244 (m), 1 172 (m), 944 (m), 879 (m), 783 (m); δH (DMSO-d6) 1 .39 (9 H, s, 3 x CH3), 4.18 (2 H, d, J = 6.3, CH2), 7.34 (2 H, d, J = 8.1 , H-3, 5), 7.48 (1 H, t, J = 6.1 , NH), 7.89 (2 H, d, J = 8.2, H-2, 6), 12.87 (1 H, s, br, COOH); δc (DMSO-d6) 28.2 (3 x CH3), 43.2 (CH2), 77.9 (C(CH3)3), 126.9 (CH), 129.2 (C-1 ), 129.3 (CH), 145.3 (C-4), 155.8 (C=O), carbamate), 167.2 (C=O, acid).
79% With hydrogenchloride; sodium hydroxide In 1,4-dioxane; water (1-1)
Synthesis of 4-(N-t-Butyloxycarbonylaminomethyl)benzoic Acid:
In 150 ml of a mixture of dioxane and water (2:1 by volume) was dissolved 7.6 g of 4-aminomethylbenzoic acid, and 50 ml of an aqueous 1 mol sodium hydroxide solution and 25 ml of a dioxane solution of 12.0 g of di-t-butyl dicarbonate were added dropwise to the solution over a period of 10 minutes.
Then, after stirring the mixture for 2.5 hours at room temperature (about 20° to 30° C.), the reaction mixture was concentrated under reduced pressure to about 1/3 of the original volume on a water bath of external temperature of from 50° C. to 60° C. and about 40 ml of 1N hydrochloric acid was added dropwise to the reaction mixture under ice-cooling to adjust the pH thereof to from 3 to 4.
Then, the reaction product was extracted three times, each time with 40 ml of ethyl acetate, the organic layer thus obtained was washed with 30 ml of purified water and 30 ml of a saturated aqueous sodium chloride solution, and after drying it with magnesium sulfate, the solvent was distilled off under reduced pressure.
The crude crystals thus obtained were washed with isopropyl ether and then recrystallized from ethyl acetate to provide 9.9 g (yield 79percent) of a colorless powder of 4-(N-t-butyloxycarbonylaminomethyl)benzoic acid.
78% With sodium hydrogencarbonate In tetrahydrofuran at 20℃; for 48 h; Stage 1 - 4-[(ter/-butoxycarbonyl)amino]methyl}benzoic acid; To a solution of 4-aminomethyl benzoic acid (19.22 g, 126 mmol) in THF (200 mL) was added saturated sodium hydrogen carbonate solution (300 mL) and di-tert-butyl dicarbonate (42.72 g, 195.7 mmol). The mixture was stirred at room temperature for 48 hours, then poured into ethyl acetate (250 mL). The aqueous layer was washed with ethyl acetate (250 mL), then acidified with 2M HCl solution. The precipitate was collected by filtration and dried under high vacuum to yield the desired product (24.6 g, 78percent yield). LC/MS: m/z 274 [M+Na]+
78% With sodium hydroxide In tetrahydrofuran at 20℃; for 8 h; To a solution of compound 1 (605 mg, 4.0 mmol) in 8.8mL of 1 N NaOH, was added a solution of (Boc)2O (960 mg, 4.4 mmol)in tetrahydrofuran (THF, 2 mL). After stirring themixture at room temperature for 8 h, THF was evaporated in vacuum with theresidues being adjusted to pH 4-5 with 1 N aqueous citric acid. Then themixture was extracted with EtOAc (3 × 25 mL). The extractions were combined,washed with brine (3 × 20 mL), dried over MgSO4 and evaporated togive compound 2 (yield: 78 percent) as a white solid. 1H-NMR (MeOH-d4, 400 MHz): δ 1.41 (s, 9H), 4.34 (s, 2H,), 7.32(d, J = 7.6 Hz, 2H), 8.01 (d, J = 7.6 Hz, 2H). 13CNMR (MeOH-d4): δ 26.7, 42.6, 78.2, 125.8, 128.5, 128.8, 144.3, 157.1, 167.6. HR-MS m/z: calcd for C13H17NNaO4,274.1050 [M-Na]+, found 274.1047 [M-Na]+.
66%
Stage #1: With sodium hydrogencarbonate In 1,4-dioxane at 0 - 20℃; for 16 h;
Stage #2: With hydrogenchloride In water
To a stirred solution of 4-(aminomethyl)benzoic acid (5 g, 33 mmol) in 1,4-dioxane (50 mL) and H2O (25 mL) was added NaHCO3 (8.3 g, 99.2 mmol) followed by Boc anhydride (10.8 g, 49.6 mmol) at 0° C. The resulting reaction mixture was stirred at room temperature for 16 h. After completion of reaction (by TLC), the volatiles were evaporated under reduced pressure and the residue was neutralized using cold 1N HCl solution. The precipitated solid was filtered and dried under reduced pressure to afford 4-(((tert-butoxycarbonyl)amino)methyl)benzoic acid (5.5 g, 66percent) as a white solid.
60%
Stage #1: With sodium hydroxide In 1,4-dioxane for 1 h;
Stage #2: With hydrogenchloride In 1,4-dioxane; water
To a solution of 4-Aminomethyl-benzoic acid (5.0 g, 33.1 mmol) in 1,4-dioxane (60.0 mL) were added 1M sodium hydroxide (30 mL), BOC-anhydride (6.8 mL, 29.8 mmol) drop wise at ice temperature and it was stirred at same temperature over a period of 60 min. The resulting mixture acidified (PH=:5.0) with 1.5 N hydrochloric acid and extracted with ethyl acetate (3X100 mL), dried over sodium sulphate. Volatiles were evaporated under reduced pressure to obtain 4-(tert-Butoxycarbonylamino-methyl)-benzoic acid as a colourless solid (5.0 g, 60 percent).
60%
Stage #1: With sodium hydroxide In 1,4-dioxane for 1 h; Cooling with ice
Stage #2: With hydrogenchloride In 1,4-dioxane; water
To a solution of 4-Aminomethyl-benzoic acid (5.0 g, 33.1 mmol) in 1,4-dioxane (60.0 mL) were added 1M sodium hydroxide (30 mL), BOC-anhydride (6.8 mL, 29.8 mmol) drop wise at ice temperature and it was stirred at same temperature over a period of 60 min.
The resulting mixture acidified (PH=5.0) with 1.5 N hydrochloric acid and extracted with ethyl acetate (3*100 mL), dried over sodium sulphate.
Volatiles were evaporated under reduced pressure to obtain 4-(tert-Butoxycarbonylamino-methyl)-benzoic acid as a colourless solid (5.0 g, 60percent).
47%
Stage #1: With sodium hydroxide In 1,4-dioxane; water at 0℃; for 1 h;
Stage #2: With potassium hydrogensulfate; water In 1,4-dioxane; ethyl acetate
Example 103 TERT-BUTYL(4-[3-[(PYRIDIN-3-YLMETHYL)AMINO]CARBONYL}-5H-PYRROLO[2,1-C][1,4]BENZODIAZEPIN-10(11H)-YL]CARBONYL}BENZYL)CARBAMATE Step A. 4-[(tert-Butoxycarbonyl)amino]methyl}benzoic acid; To a solution of 4-(aminomethyl)benzoic acid (5.00 g, 0.0331 mol) in dioxane (60 mL), water (30 mL), and 1 M sodium hydroxide (34 mL, 0.034 mol) at 0° C. was added di-tert-butylpyrocarbonate (7.94 g, 0.0364 mol) and the reaction mixture stirred at 0° C. for 1 hour. The reaction mixture was concentrated in vacuo to 30 mL, ethyl acetate (80 mL) added and the mixture acidified to pH 4 by the addition of 1 M aqueous potassium hydrogen sulfate solution with vigorous stirring. The organic phase was separated, washed with water (80 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo to afford a white solid. Recrystallization from ethyl acetate (60 mL) gave the title compound (3.94 g, 47percent) as a white crystalline solid, m.p. 165° C. MS [(-)ESI, m/z]: 250 [M-H]- Anal. Calcd for C13H17NO4: C, 62.14; H, 6.82; N, 5.57. Found: C, 61.74; H, 6.51; N, 5.42.
46.5%
Stage #1: With sodium hydroxide In water; butan-1-ol at 0 - 20℃; for 3 h;
Stage #2: With citric acid In water; butan-1-ol at 0℃;
Step 2; Preparation of 4-((t-butoxycarbonylamino)niethyI)benzoic acid.; To a solution of 4-aminomethylbenzoic acid (5 g, 33 mmol) in water maintained at 0 0C, was added 5percent aqueous NaOH solution (100 mL), followed by dropwise addition of Boc anhydride (15 mL, 66 mmol) in n-butanol (10 mL). Subsequently, the reaction mixture was stirred at room temperature for 3 hours. Upon completion, as monitored by TLC using DCM:MeOH (9: 1) as the eluent, the reaction mixture was poured in ice water, acidified with citric acid upto pH 4. On standing at room temperature for 10 minutes the precipitate formed was filtered, washed with water (100 mL) and dried to give the Boc protected product (6.5 g. 46.5 percent yield).
46.5%
Stage #1: With sodium hydroxide In water; butan-1-ol at 0 - 20℃;
Stage #2: With citric acid In water; butan-1-olCooling with ice
To a solution of 4-aminomethylbenzoic acid (5 g, 33 mmol) in water maintained at 0° C., was added 5percent aqueous NaOH solution (100 mL), followed by dropwise addition of Boc anhydride (15 mL, 66 mmol) in n-butanol (10 mL).
Subsequently, the reaction mixture was stirred at room temperature for 3 hours.
Upon completion, as monitored by TLC using DCM:MeOH (9:1) as the eluent, the reaction mixture was poured in ice water, acidified with citric acid up to pH 4.
On standing at room temperature for 10 minutes the precipitate formed was filtered, washed with water (100 mL) and dried to give the Boc protected product (6.5 g, 46.5percent yield).

Reference: [1] Patent: WO2008/53131, 2008, A1, . Location in patent: Page/Page column 58; 59-60
[2] Patent: WO2008/40934, 2008, A1, . Location in patent: Page/Page column 57-58
[3] Patent: WO2010/20556, 2010, A1, . Location in patent: Page/Page column 206
[4] Journal of Medicinal Chemistry, 2016, vol. 59, # 3, p. 965 - 984
[5] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 4, p. 501 - 508
[6] Journal of Organic Chemistry, 1996, vol. 61, # 25, p. 8811 - 8818
[7] Patent: US2012/209005, 2012, A1, . Location in patent: Page/Page column 35
[8] European Journal of Medicinal Chemistry, 2017, vol. 129, p. 124 - 134
[9] Journal of the American Chemical Society, 2017, vol. 139, # 50, p. 18365 - 18375
[10] Journal of Medicinal Chemistry, 2001, vol. 44, # 10, p. 1491 - 1508
[11] Patent: EP1080070, 2006, B1, . Location in patent: Page/Page column 12
[12] Journal of the American Chemical Society, 2010, vol. 132, # 49, p. 17366 - 17369
[13] Journal of Medicinal Chemistry, 2012, vol. 55, # 7, p. 3331 - 3341
[14] Patent: WO2011/23986, 2011, A1, . Location in patent: Page/Page column 29; 31
[15] Bioorganic Chemistry, 2002, vol. 30, # 4, p. 285 - 301
[16] Journal of Medicinal Chemistry, 1995, vol. 38, # 19, p. 3798 - 3805
[17] Tetrahedron Letters, 2008, vol. 49, # 42, p. 6033 - 6035
[18] Organic and Biomolecular Chemistry, 2008, vol. 6, # 23, p. 4356 - 4373
[19] Patent: US5166403, 1992, A,
[20] Chemistry - A European Journal, 2014, vol. 20, # 5, p. 1258 - 1262
[21] Patent: WO2011/154708, 2011, A1, . Location in patent: Page/Page column 65-66
[22] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 16, p. 4133 - 4139
[23] Chemical Communications, 2015, vol. 51, # 44, p. 9197 - 9200
[24] Patent: US6375926, 2002, B1,
[25] Patent: US2012/295874, 2012, A1, . Location in patent: Page/Page column 174
[26] Journal of Medicinal Chemistry, 1986, vol. 29, # 4, p. 448 - 453
[27] Journal of Medicinal Chemistry, 2008, vol. 51, # 8, p. 2447 - 2456
[28] Patent: WO2011/21209, 2011, A1, . Location in patent: Page/Page column 49; 50
[29] Patent: US2012/101099, 2012, A1, . Location in patent: Page/Page column 18; 19
[30] Patent: US2006/287522, 2006, A1, . Location in patent: Page/Page column 50
[31] Patent: WO2009/47615, 2009, A2, . Location in patent: Page/Page column 24
[32] Patent: US2010/222379, 2010, A1, . Location in patent: Page/Page column 11
[33] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 6, p. 553 - 557
[34] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 11, p. 1359 - 1362
[35] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 6, p. 1021 - 1029
[36] Journal of Medicinal Chemistry, 2004, vol. 47, # 10, p. 2411 - 2413
[37] Journal of Medicinal Chemistry, 2005, vol. 48, # 17, p. 5530 - 5535
[38] Patent: US6521658, 2003, B1,
[39] Patent: US5486525, 1996, A,
[40] Patent: US5656660, 1997, A,
[41] Patent: EP1273571, 2003, A1,
[42] Patent: US7169759, 2007, B1, . Location in patent: Page/Page column 11; 24-25
[43] Patent: US6680311, 2004, B1, . Location in patent: Page/Page column 151
[44] Patent: EP1181269, 2004, B1, . Location in patent: Page 21
[45] Patent: EP1389460, 2004, A1, . Location in patent: Page/Page column 44
[46] Patent: WO2004/89925, 2004, A1, . Location in patent: Page 72
[47] Patent: EP1550657, 2005, A1, . Location in patent: Page/Page column 109
[48] Russian Journal of General Chemistry, 2010, vol. 80, # 12, p. 2572 - 2589
[49] Journal of the American Chemical Society, 2012, vol. 134, # 10, p. 4465 - 4468
[50] RSC Advances, 2014, vol. 4, # 76, p. 40444 - 40448
[51] Patent: WO2017/87695, 2017, A1, . Location in patent: Paragraph 00103; 00104
[52] Patent: US5231102, 1993, A,
  • 35
  • [ 56-91-7 ]
  • [ 34619-03-9 ]
  • [ 33233-67-9 ]
Reference: [1] Patent: EP2439204, 2012, A1, . Location in patent: Page/Page column 45
  • 36
  • [ 56-91-7 ]
  • [ 33233-67-9 ]
Reference: [1] Patent: US5939420, 1999, A,
[2] Patent: US5958930, 1999, A,
[3] Patent: US5877178, 1999, A,
  • 37
  • [ 56-91-7 ]
  • [ 24424-99-5 ]
  • [ 506-59-2 ]
  • [ 541-41-3 ]
  • [ 33233-67-9 ]
Reference: [1] Patent: US5098900, 1992, A,
  • 38
  • [ 123-91-1 ]
  • [ 56-91-7 ]
  • [ 24424-99-5 ]
  • [ 7732-18-5 ]
  • [ 33233-67-9 ]
Reference: [1] Patent: US5476847, 1995, A,
  • 39
  • [ 56-91-7 ]
  • [ 58632-95-4 ]
  • [ 33233-67-9 ]
Reference: [1] Patent: US4873253, 1989, A,
  • 40
  • [ 56-91-7 ]
  • [ 24424-99-5 ]
  • [ 33233-67-9 ]
Reference: [1] Patent: US6235731, 2001, B1,
  • 41
  • [ 56-91-7 ]
  • [ 58632-95-4 ]
  • [ 33233-67-9 ]
Reference: [1] Patent: EP284632, 1988, A1,
  • 42
  • [ 56-91-7 ]
  • [ 24424-99-5 ]
  • [ 33233-67-9 ]
Reference: [1] Patent: EP386839, 1997, B1,
  • 43
  • [ 56-91-7 ]
  • [ 13303-10-1 ]
  • [ 33233-67-9 ]
Reference: [1] Roczniki Chemii, 1971, vol. 45, p. 655 - 656
  • 44
  • [ 56-91-7 ]
  • [ 66389-80-8 ]
Reference: [1] Journal of the American Chemical Society, 2012, vol. 134, # 10, p. 4465 - 4468
  • 45
  • [ 56-91-7 ]
  • [ 42383-05-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 1, p. 161 - 175
  • 46
  • [ 56-91-7 ]
  • [ 6232-11-7 ]
YieldReaction ConditionsOperation in experiment
97% With thionyl chloride In methanol at 20℃; for 16 h; 4-(Aminomethyl)benzoic acid (302 mg, 2.00 mmol) was dissolved in MeOH (30 mL) and thionyl chloride (1.16 mL, 16.0 mmol) was carefully added dropwise at rt. The reaction mixture was stirred overnight at rt. Afterwards the solvent was removed under reduced pressure to yield 15d. Colorless solid, mp 234 °C, yield 390 mg (97 percent). C9H12ClNO2 (201.7). Rf = 0.22 (ethyl acetate/1percent diethylmethylamine, detection: 254 nm). 1H NMR (400 MHz, DMSO-D6): δ [ppm] = 3.86 (s, 3H, CO2CH3), 4.10 (s, 2H, H3NCH2), 7.63-7.67 (m, 2H, 3-HB, 5-HB), 7.96-8.01 (m, 2H, 2-HB, 6-HB), 8.61 (br s, 3H, NH3). 13C NMR (101 MHz, DMSO-D6): δ [ppm] = 41.7 (1C, H3NCH2), 52.2 (1C, CO2CH3), 129.2 (2C, C-3B, C-5B), 129.3 (2C, C-2B, C-6B), 129.5 (1C, C-1B), 139.4 (1C, C-4B), 165.9 (1C, CO2CH3). FT-IR: ν [cm-1] = 2963 (NH3+), 2878 (C-Haliph.), 2573 (NH3+), 1678 (C=O), 1597, 1578, 1477 (C=CAr), 864 (Ar-Hout of plane). HRMS (APCI): m/z = 166.0865 (calcd. 166.0863 for C9H12NO2 [M+H]+). HPLC: tR = 6.4 min, purity 99.9 percent.
Reference: [1] Angewandte Chemie - International Edition, 2011, vol. 50, # 21, p. 4872 - 4875
[2] European Journal of Medicinal Chemistry, 2017, vol. 129, p. 124 - 134
[3] Patent: US5585381, 1996, A,
  • 47
  • [ 67-56-1 ]
  • [ 56-91-7 ]
  • [ 6232-11-7 ]
YieldReaction ConditionsOperation in experiment
99% at 0℃; for 24 h; Reflux Example 1: Preparation of N-(2-aminophenyl)-4-((4-bromo-5,6-dimethoxy-l- oxoisoindolin-2-yl) methyl)benzamideStep 1 : Preparation of methyl 4-(aminomethyl)benzoate hydrochloride4-Aminomethylbenzoic acid (2.0 g, 13 mmol) was dissolved in MeOH(5.0 mL), thionylchloride (2.9 mL, 3 equiv.) was slowly added thereto at 0 °C and fluxed for 24 hrs. The mixture thus obtained was distilled under a reduced pressure to remove the solvent and thionyl chloride, and dried under vacuum to obtain the title compound (2.7 g, 99 percent).1H NMR (300 MHz, D2O): δ 7.93 (d, 2H, J = 8.4 Hz), 7.41 (d, 2H, J = 8.4Hz), 4.12(s, 2H), 3.79 (s, 3H).
93% at 0 - 75℃; for 5 h; Compound 5 (1.5 g, 10 mmol) was dissolved in 200 mL MeOH, thenacetyl chloride (2.4 g, 30 mmol) was added dropwise at 0 °C; themixed solution was refluxed at 75 °C for 5 h. The solvent wasevaporated under vacuum, the product was washed by diethylether to give compound 6, a white solid powder (1.7 g, 93percent).
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 16, p. 6516 - 6532
[2] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 19, p. 4189 - 4206
[3] Patent: WO2010/131922, 2010, A2, . Location in patent: Page/Page column 28
[4] Organic Letters, 2017, vol. 19, # 7, p. 1768 - 1771
[5] Journal of Medicinal Chemistry, 1994, vol. 37, # 12, p. 1810 - 1822
[6] Journal of Medicinal Chemistry, 2013, vol. 56, # 21, p. 8948 - 8952
[7] Angewandte Chemie, International Edition, 2015, vol. 54, # 1, p. 276 - 279[8] Angewandte Chemie, 2015, vol. 127, # 1, p. 278 - 281,4
[9] Molecules, 2008, vol. 13, # 5, p. 1111 - 1119
[10] Journal of the American Chemical Society, 2015, vol. 137, # 5, p. 1983 - 1992
[11] European Journal of Medicinal Chemistry, 2017, vol. 134, p. 185 - 206
[12] Journal of Organic Chemistry, 1995, vol. 60, # 21, p. 6970 - 6979
[13] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 15, p. 4455 - 4458
[14] Chemical Communications, 2014, vol. 50, # 97, p. 15341 - 15344
[15] Journal of Medicinal Chemistry, 2016, vol. 59, # 21, p. 9942 - 9959
[16] Patent: JP5871223, 2016, B2, . Location in patent: Paragraph 0039
[17] Patent: WO2018/71740, 2018, A1, . Location in patent: Page/Page column 27
  • 48
  • [ 56-91-7 ]
  • [ 71989-31-6 ]
  • [ 164470-64-8 ]
YieldReaction ConditionsOperation in experiment
90% With sodium hydrogencarbonate In 1,4-dioxane; water at 20℃; for 2 h; (4-aminomethyl)-benzoic acid (4.9 g, 1. 1 equiv. ) was dissolved in 5percent NaHCO3 150 ml in water and stirred. N- (9- Fluorenylmethoxycarbonyl) -L-proline (Fmoc, 1 equiv. , lOg) was dissolved in an equivalent amount of dioxane and added. The reaction was allowed to stir at room temperature. After two hours, 10percent citric acid in water 75 ml was added. A white solid precipitated upon addition. The solid was washed filtered and washed with hexane. The solid was dissolved in THF and allowed to dry overnight over MGSO. The following day, the solution was filtered, crystallized from THF and hexane, and placed under a drying vacuum (90percent yield). ESIMS: (M+H) + Calcd, 373.1 ; Found, 374.1.
Reference: [1] Journal of the American Chemical Society, 2003, vol. 125, # 39, p. 11804 - 11805
[2] Patent: WO2004/99106, 2004, A2, . Location in patent: Page 18-19; 27-28
  • 49
  • [ 56-91-7 ]
  • [ 82911-69-1 ]
  • [ 164470-64-8 ]
YieldReaction ConditionsOperation in experiment
23% With sodium hydrogencarbonate In water; acetone at 20℃; 4-(Aminomethyl)benzoic acid (304 mg, 2.0 mmol) was stirred in 10percent Sodium hydrogencarbonate (sat aq, 10 ml). N-(9-Fluorenylmethoxycarbonyloxy)succinimide (680 mg, 2.0 mmol) and acetone (10 ml) was added and thick suspension was formed. Water (10 ml) was added to give an almost clear mixture that was stirred at room temperature over week-end. The mixture was washed with dichloromethane (a thick precipitate was formed in the water layer). The water layer was acidified with HCI (1 M) and extracted with dichloromethane (the precipitate moved into the dichloromethane layer). The precipitate was filtered off, dissolved in acetone and the insoluble material was filtered off. This latter filtrate was evaporated and dried on pump to yield a pure product (174 mg, 0.466 mmol, 23 percent). H NMR (400 MHz, DMSO-cfe) δ ppm 4.25 (m, 3 H) 4.38 (d, J^6.6 Hz, 2 H) 7.26 - 7.46 (m, 6 H) 7.70 (d, J=7.6 Hz, 2 H) 7.81 - 7.99 (m, 5 H) 12.85 (br. s., 1 H). 3C NMR (101 MHz, DMSO-cfe) δ ppm 43.55, 46.82, 65.33, 120.1 1 , 125.14, 126.96, 127.03, 127.59, 129.37, 140.78, 143.86, 144.90, 156.41 , 167.19.
Reference: [1] Organic letters, 2001, vol. 3, # 26, p. 4239 - 4242
[2] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 5, p. 528 - 530
[3] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 1, p. 161 - 175
[4] Angewandte Chemie - International Edition, 2011, vol. 50, # 19, p. 4423 - 4427
[5] Patent: WO2015/63694, 2015, A1, . Location in patent: Page/Page column 39
[6] Chemical Communications, 2010, vol. 46, # 8, p. 1221 - 1223
[7] Organic Process Research and Development, 2001, vol. 5, # 4, p. 445 - 449
[8] Biological Chemistry, 2015, vol. 396, # 1, p. 45 - 52
  • 50
  • [ 56-91-7 ]
  • [ 28920-43-6 ]
  • [ 164470-64-8 ]
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 16, p. 6518 - 6524
[2] Tetrahedron, 1998, vol. 54, # 50, p. 15063 - 15086
[3] Organic Letters, 2008, vol. 10, # 10, p. 1881 - 1884
[4] Russian Journal of General Chemistry, 2010, vol. 80, # 12, p. 2572 - 2589
[5] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 3, p. 873 - 879
[6] Patent: US9422239, 2016, B1, . Location in patent: Page/Page column 89
  • 51
  • [ 56-91-7 ]
  • [ 497-19-8 ]
  • [ 164470-64-8 ]
Reference: [1] Patent: US2003/187027, 2003, A1,
[2] Patent: US2004/72849, 2004, A1,
  • 52
  • [ 56-91-7 ]
  • [ 164470-64-8 ]
Reference: [1] Patent: US6191171, 2001, B1,
  • 53
  • [ 56-91-7 ]
  • [ 123986-64-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 10, p. 2411 - 2413
[2] Journal of Medicinal Chemistry, 2001, vol. 44, # 10, p. 1491 - 1508
[3] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 4, p. 501 - 508
[4] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 1, p. 161 - 175
[5] Patent: WO2011/21209, 2011, A1,
[6] Patent: US2012/101099, 2012, A1,
[7] Patent: WO2008/40934, 2008, A1,
  • 54
  • [ 56-91-7 ]
  • [ 209783-80-2 ]
Reference: [1] Patent: WO2017/81278, 2017, A1,
  • 55
  • [ 56-91-7 ]
  • [ 187283-17-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2018, vol. 61, # 13, p. 5719 - 5732
  • 56
  • [ 56-91-7 ]
  • [ 24424-99-5 ]
  • [ 156866-52-3 ]
Reference: [1] Patent: US2003/232860, 2003, A1, . Location in patent: Page 13
  • 57
  • [ 56-91-7 ]
  • [ 156866-52-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 10, p. 2411 - 2413
[2] Patent: WO2011/21209, 2011, A1,
[3] Patent: US2012/101099, 2012, A1,
[4] Journal of the American Chemical Society, 2012, vol. 134, # 10, p. 4465 - 4468
[5] RSC Advances, 2013, vol. 3, # 38, p. 17150 - 17155
[6] Patent: WO2008/40934, 2008, A1,
  • 58
  • [ 56-91-7 ]
  • [ 885466-67-1 ]
Reference: [1] Angewandte Chemie - International Edition, 2012, vol. 51, # 46, p. 11463 - 11467
  • 59
  • [ 56-91-7 ]
  • [ 724741-75-7 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 38, p. 11549 - 11553[2] Angew. Chem., 2017, vol. 129, # 38, p. 11707 - 11711,5
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 56-91-7 ]

Chidamide Related Intermediates

Chemical Structure| 1126-74-5

[ 1126-74-5 ]

3-(Pyridin-3-yl)acrylic acid